Current experimental mouse models for CAVD research predominantly feature single-gene mutations disrupting lipid metabolism, notably low-density lipoprotein receptor-deficient (Ldlr−/−) and apolipoprotein E-deficient (Apoe−/−) mice [64]. This evidence concerns the gene APOE and congenital bilateral aplasia of vas deferens from CFTR mutation.